From all my research I am going to call .15 to .18 as the bottom. After that we will see a very slow rise depending on FDA news. Still not a stock that is worth over $1 per share.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.